21
Participants
Start Date
May 31, 1997
Primary Completion Date
February 1, 2005
Study Completion Date
February 1, 2005
filgrastim
carboplatin
cyclophosphamide
etoposide
autologous bone marrow transplantation
peripheral blood stem cell transplantation
Johns Hopkins Oncology Center, Baltimore
Collaborators (2)
Amgen
INDUSTRY
Baxter Healthcare Corporation
INDUSTRY
Nexell Therapeutics Inc
UNKNOWN
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER